The primary end point , the difference in polyneuropathy progression between treatments , was measured by the Neuropathy Impairment Score plus @ nerve tests ( NIS +@ ) which ranges from @ ( no neurological deficits ) to @ points ( no detectable peripheral nerve function ) .